Synthetic G-quadruplex components for predictable, precise two-level control of mammalian recombinant protein expression

Melinda Pohle,Edward Curry,Suzanne Gibson,Adam Brown
DOI: https://doi.org/10.1101/2024.09.10.612233
2024-09-14
Abstract:Control of mammalian recombinant protein expression underpins the manufacture and performance of all biopharmaceutical products. However, routine optimization of protein expression levels in these applications is hampered by a paucity of genetic elements that function predictably across varying molecular formats and host cell contexts. Herein, we describe synthetic genetic components that are specifically built to simplify bioindustrial expression cassette design processes. Synthetic G-quadruplex elements with varying sequence feature compositions were systematically designed to exhibit a wide-range of regulatory activities, and inserted into identified optimal positions within a standardized, bioindustry compatible core promoter-5' UTR control unit. The resulting library tuned protein production rates over two orders of magnitude, where DNA and RNA G-quadruplexes could be deployed individually, or in combination to achieve synergistic two-level regulatory control. We demonstrate these components can predictably and precisely tailor protein expression levels in i) varying gene therapy and biomanufacturing cell hosts, and ii) both plasmid DNA and synthetic mRNA contexts. As an exemplar use-case, a vector design platform was created to facilitate rapid optimization of polypeptide expression ratios for difficult-to-express multichain products. Permitting simple, predictable titration of recombinant protein expression, this technology should prove useful for gene therapy and biopharmaceutical manufacturing applications.
Bioengineering
What problem does this paper attempt to address?
This paper aims to solve the problem of recombinant protein expression control in mammalian cells. Specifically, the researchers have developed a method based on synthetic G - quadruplex (G4) elements for precisely regulating recombinant protein expression in mammalian cells. These G4 elements are designed to be inserted into standardized bioindustrial expression cassettes to achieve predictable and precise control of protein expression levels. ### Research Background In biopharmaceutical production and gene therapy, controlling recombinant protein expression in mammalian cells is very important. However, at present, there is a lack of genetic elements that can stably function in different molecular formats and host cell environments, which limits the routine optimization of protein expression levels. Therefore, new technologies need to be developed to achieve more refined control of protein expression. ### Research Objectives 1. **Develop a synthetic G4 element library**: Design and construct a series of synthetic G4 elements with different sequence characteristics. These elements can act independently or synergistically at the DNA and RNA levels to achieve two - level regulatory control of protein expression. 2. **Verify the functions of G4 elements**: By inserting these G4 elements into the standardized core promoter - 5'UTR control unit, verify their functions in different cell types and molecular formats (such as plasmid DNA and synthetic mRNA). 3. **Application examples**: Demonstrate that these G4 elements can be used to rapidly optimize the expression ratios of multi - chain protein products, thereby improving the production efficiency of difficult - to - express proteins. ### Main Findings - **Optimization of G4 element positions**: The researchers determined the optimal insertion positions of G4 elements in the core promoter - 5'UTR control unit, and these positions can significantly affect protein expression levels. - **Wide regulatory range**: Through systematic design and screening, the researchers constructed a library containing 80 different G4 elements, which can regulate protein expression levels by two orders of magnitude. - **Predictability and precision**: These G4 elements show consistent regulatory effects in different cell types and molecular formats, demonstrating their potential application value in biopharmaceutical production and gene therapy. In conclusion, this paper proposes a new method for precisely controlling recombinant protein expression in mammalian cells by using synthetic G4 elements, providing new tools and techniques for biopharmaceutical production and gene therapy.